ProCE Banner Series

Thrombotic Risk in Patients With Polycythemia Vera | Identify When to Intervene With Jakafi® (ruxolitinib)

Learning Objectives

  • Encourage participants to clinically assess how they would manage a real-world patient with PV
  • Recognize the correlation between elevated blood counts and thrombotic risk by applying data from the CYTO-PV Study
  • Evaluate treatment options in PV utilizing the RESPONSE and MAJIC-PV trials that investigated Jakafi® (ruxolitinib) vs best available therapy
  • Understand when to intervene and potential outcomes for patients with PV

All Events

Thrombotic Risk in Patients With Polycythemia Vera | Identify When to Intervene With Jakafi® (ruxolitinib)

Upcoming Events

January

29

2025

12:15 PM - 12:45 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Patricia Kropf, MD

Director of Acute Leukemia, Myeloproliferative and Myelodysplastic Syndromes
Novant Cancer Institute